Trials / Completed
CompletedNCT03452605
The Effect of Cocoa Flavanol on the BOLD Response and Cognitive Function in Type 1 Diabetes
Effect of Acute Cocoa Flavanol Intake on the BOLD Response and Cognitive Function in Patients With Type 1 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Vrije Universiteit Brussel · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Type 1 Diabetes (T1D) is associated with microvascular changes in the brain, which can cause cognitive dysfunction. Cocoa flavanols (CF) can stimulate vasodilation, resulting in enhanced cerebral blood flow and better cognitive function. This study aimed to investigate whether acute CF supplementation can improve cognitive function and the hemodynamic (BOLD) response in T1D patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | cocoa flavanol supplementation | cocoa flavanols (containing 196 mg epicatechin) |
Timeline
- Start date
- 2015-11-20
- Primary completion
- 2017-03-15
- Completion
- 2017-03-15
- First posted
- 2018-03-02
- Last updated
- 2018-03-02
Source: ClinicalTrials.gov record NCT03452605. Inclusion in this directory is not an endorsement.